Modified EASIX scores predict severe CRS/ICANS in patients with acute myeloid leukemia following CLL1 CAR-T cell therapyYifan Zhao, Mingfeng Zhao, Xiaoyuan He et al.|Annals of Hematology|2024Cited by 32
Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological MalignanciesXinping Cao, Mingfeng Zhao, Xin Jin et al.|Current Treatment Options in Oncology|2023Cited by 25
A CAR-T response prediction model for r/r B-NHL patients based on a T cell subset nomogramXiaomei Zhang, Mingfeng Zhao, Rui Sun et al.|Cancer Immunology Immunotherapy|2024Cited by 7
A CAR-T response prediction model for r/r B-NHL patients based on a T-cell subset nomogramXiaomei Zhang, Mingfeng Zhao, Rui Sun et al.|Research Square|2023Cited by 0
A novel fourth generation of CAR-T cells: CD19 CAR-T cells engineered to express membrane-bound interleukin-15 and CXCR5 for the treatment of lymphomaXinping Cao, Jile Liu, Mohan Zhao et al.|Clinical and Experimental Medicine|2025Cited by 0